VC firm invests £9m into North West growth companies
The Business Desk.com – May 23, 2020
Chester-based, venture capital specialist, Deepbridge Capital has revealed that during the 2019/20 tax year it provided more than £9m of investment across 27 North West businesses.
Full Story : https://www.thebusinessdesk.com/news
New approach for immediate pain free diagnosis of oral cancers
PHARMIWEB.COM – Mar 6, 2020
Following Phase I funding awarded in March 2019, Zilico announced that they have been awarded Phase II funding as part of an initiative by SBRI Healthcare. It will help to identify innovations tackling healthcare problems in the area of dentistry, oral health and oral cancers.
Full Story : https://www.pharmiweb.com/press-release
ZILICO SUPPORT ACCESS TO VITAL CERVICAL CANCER SCREENING AND DETECTION IN REMOTE AREAS
UMI – Nov 15, 2019
Manchester-based medical technology company Zilico Ltd are ensuring that women living in remote areas of the UK who need a colposcopic examination benefit from ZedScan™, a diagnostic device that improves the detection and diagnosis of cervical cancer.
Full Story : https://www.weareumi.co.uk/news
Former Rangers star visits Dundee hospital to donate specialist cancer equipment
Evening Telegraph – Jul 17, 2019
Ex-Rangers and Scotland winger Willie Henderson presented Ninewells staff with the ZedScan device on behalf of the Michelle Henderson Cervical Cancer Trust.
The ZedScan uses electrical impedance spectroscopy technology to detect abnormalities before they develop into cancer.
Full Story : https://www.eveningtelegraph.co.uk
Cervical Cancer Diagnostic Market SWOT and Supply Chain Analysis 2019-2026 by Top Players
Digital Journal – May 6, 2019
This report focuses on the global top players which are Guided Therapeutics, Beckman Coulter, Inc., QIAGEN, Arbor Vita Corporation, Becton, Dickinson and Company, Abbott Laboratories, Dell Guided Therapeutics, Inc., F. Hoffmann-La Roche Ltd, Zilico Ltd, Hologic, Inc., Quest Diagnostics, Inc, Cooper Surgical, Inc., Siemens, OncoHealth Corporation.
Full Story : http://www.digitaljournal.com
Excellence in Supply Awards 2019 - Shortlist Announced!
North West Procurement Development – Apr 29, 2019
The finalists for the first NHS in the Midlands Excellence in Supply Awards have been announced and Zilico Ltd have been shortlisted for the Clinical Innovation Award.
Full Story : https://www.nwprocurement.co.uk
Portable Cancer Screen Devices Market Will Reflect Significant Growth Prospects during 2018 – 2028
Amazing Herald – Apr 22, 2019
Incidence of cancer is rising rapidly in all the countries. Early detection increases the chances of survival. According to WHO, one in every 12 women has the risk of breast abnormality. New methods and technologies are being developed for the early detection of cancer. The properties of the healthy cells vary when compared to the abnormal cancerous cells. Portable cancer screen devices detect the slight differences in the abnormal tissues. Unlike mammography used for detection of breast cancer the portable cancer screening device is radiation free, non-touch and does not pain. The portable cancer screening device is a boon for cancer diagnosis test in hospitals, can be used for regular preventive health check-ups, and also for large scale screening semi-urban and rural areas.
Full Story : https://amazingherald.com
Winners of the 2019 HSJ Partnership Awards announced
HSJ – Mar 21, 2019
The outstanding work that organisations are doing in partnership with the NHS was recognised with winners named in 16 categories at the 2019 HSJ Partnership Awards.
Zilico Ltd and Sheffield Teaching Hospitals Foundation Trust were the winners in the Medical Device or Hardware Innovation Award category.
Full Story : https://www.hsj.co.uk/
Insightful Forecast on Expansion of Portable Cancer Screen Devices Market During 2018 – 2028
Daily Chronicle – Feb 25, 2019
Incidence of cancer is rising rapidly in all the countries. Early detection increases the chances of survival.
Portable cancer screen devices market: Key Players – Some of the major players identified in portable cancer screen devices market. are AdDent, Inc, Forward Science, LED Apteryx Inc., Breastlight, Zilico, Braster S.A, Bremed Ltd., TruScreen, Niramai among others.
Full Story : http://www.dailychronicle24.com/
SBRI Healthcare awards £1.25m to musculoskeletal disorder and oral health innovations
Cambridge Network – Feb 21, 2019
SBRI Healthcare has awarded £1.25 million to help fund the development of thirteen separate innovations relating to musculoskeletal disorder and dentistry, oral health and oral cancers. The pioneering projects were discovered through a nationwide call by SBRI Healthcare earlier this year for innovations to tackle healthcare problems in these fields.
Zilico have been awarded £99, 752 for the development of an oral pre-cancer/cancer in-vivo, real time diagnostic based on electrical characterisation of tissue.
Full Story : https://www.cambridgenetwork.co.uk/news
Cervical Cancer Diagnostic Market 2025
Eagle Chronicle – Feb 18, 2019
Crystal Market Research has added the report on Cervical Cancer Diagnostic Market for the forecast till 2025, the report comprises of the estimation of the global Cervical Cancer Diagnostic Market.
Key players include Zilico Ltd.
Full Story : https://eaglechronicle.com/
Finalists for HSJ Partnership Awards 2019 revealed
Health Services Journal – Jan 22, 2019
The shortlist for the HSJ Partnership Awards 2019 has been announced today.
Zilico have been shortlisted in the Medical Device or Hardware category. The winners will be announced at the HSJ awards dinner on 20th March 2019.
Full Story : https://www.hsj.co.uk/quality-and-performance/
Zilicos breaking new ground with a tool to diagnose cervical cancer
Proactive Investors – Jan 18, 2019
Watch the interview with CEO, Sameer Kothari as he talks to Proactive Investors about ZedScan.
Full Story : https://www.proactiveinvestors.co.uk/
Scottish football legend Willie Henderson provides life-saving machines for cervical cancer patients
The Press and Journal – Dec 31, 2018
A Scottish football legend who dedicated himself to cancer causes following the death of his daughter has helped provide funding for live saving devices at Aberdeen Royal Infirmary (ARI).
Willie Henderson was at the hospital on Monday to celebrate the arrival of two ZedScan machines, which use innovative technology to detect cell abnormalities in the cervix and drastically reduce the time taken to diagnose cervical cancer in women.
Full Story : https://www.pressandjournal.co.uk/
Med-Tech companies triumph at the Bionow Awards
Catapult Ventures – Dec 3, 2018
The outstanding companies and leaders of the North’s life sciences sector – which is worth more than £13bn to the economy- were honoured last night at the 17th annual Bionow Awards.
Blueberry Therapeutics, C4X Discovery, Zilico and LightOx all won prizes for the application of their cutting edge technologies to the life sciences sector.
Full Story : http://www.catapult-ventures.com/
Zilico appoint new head of quality assurance and regulatory affairs
Med Tech Innovation – Oct 31, 2018
Zilico, which develops products to help with cancer diagnoses, has appointed Kirsty Cook as its head of quality assurance and regulatory affairs.
Full Story : https://www.med-technews.com/news
Manchester based MedTech gains further adoption in Scotland following funding from Scottish Cervical Cancer charity
BBP Media – Aug 7, 2018
Zilico, a medical technology company, based at Manchester Science Park continues to see the adoption of ZedScan™ expand, as the Michelle Henderson Cervical Cancer Trust, funds the purchase of two ZedScan devices at Aberdeen Royal Infirmary’s colposcopy unit, to help prevent women developing cervical cancer.
Full Story : https://www.bbpmedia.co.uk/
Scotland star’s charity donates devices to help north-east cancer patients
Evening Express – Jul 31, 2018
A charity has funded new equipment which could benefit up to 2,500 cervical cancer patients in the north-east every year.
Football legend Willie Henderson donated two Zedscan diagnostic devices to the colonoscopy unit at Aberdeen Royal Infirmary (ARI) yesterday.
Full Story : https://www.eveningexpress.co.uk/
Zilico/ International Oncology Pilot
Tech Emerge – Apr 18, 2018
As an adjunct to colposcopy, Zedscan lends greater efficiency in detecting cervical cancer, ultimately saving lives and money. In their pilot in India with International Oncology, they aimed to increase early detection and quickly enable treatment.
Full Story : http://www.techemerge.org/
Deepbridge puts £3m into Zilico
Angel News – Feb 19, 2018
Zilico, part of the Deepbridge Technology Growth EIS portfolio, has secured investment of £13.7 million in its latest funding round.
Deepbridge has contributed £3 million of this, with other backers including MaxHealth Medicine Group.
Full Story : https://www.angelnews.co.uk/
Tech firm Zilico secures £13.5m investment to boost expansion
Manchester Evening News – Feb 13, 2018
Tech firm Zilico has secured more than £13.5m in new investments to bolster its expansion plans.
The company, which is based at Manchester Science Park, has signed a strategic deal with the MaxHealth Medicine Group to allow it to sell ZedScan, the cervical cancer diagnostic system, to the Chinese market.
Full Story : https://www.manchestereveningnews.co.uk/business/business-news/
Zilico Raises $19M in Total Investments
FINSMES – Feb 2, 2018
Zilico, a Manchester, UK-based developer of a cervical cancer diagnostic system, raised a $19m in total funding.
The company will receive minimum royalties of $12m and investments totalling $7M.
Backers included the MaxHealth Medicine Group (stock code: 836163 (NEEQ) and Deepbridge Capital (UK).
Full Story : http://www.finsmes.com/
ZedScan featured in the Mail on Sunday's Health supplement.
Mail on Sunday – Jan 16, 2018
As a pilot site for primary HPV screening, Sheffield Teaching Hospital NHS Foundation Trust found that by using ZedScan™ as part of their routine colposcopy examination, clinicians were able to release high risk-HPV positive but cytology negative patients back to routine screening.
Full Story : http://dailym.ai/2mxyeMN
Manchester diagnostics company raising awareness for gynaecological cancers
Medical Plastics News – Sep 26, 2017
Zilico, who are based on the Manchester Science Park, is supporting The Eve Appeal’s UK campaign to help people become more aware of the early signs and symptoms.
The company is highlighting stories by clinicians, patients and their partners on social media throughout the month.
Full Story : https://www.medicalplasticsnews.com/
Cervical cancer diagnostic company welcomes new board member
Manchester Science Partnership website – Mar 13, 2017
Manchester Science Park based cervical cancer diagnostic specialist Zilico has today announced that it has appointed new member, Dr Savvas Neophytou to its Board of Directors.
Full Story : https://mspl.co.uk/news/
Cervical cancer diagnostic company announces operational changes
Manchester Science Partnership website – Feb 14, 2017
Cervical cancer diagnostic specialist Zilico, has today announced a number of operational changes designed to better align its operations.
Going forward, Zilico's flagship product ZedScan™, which improves the speed and accuracy in diagnosing pre-cancerous conditions of the cervix, will be sold directly to hospitals in Great Britain (Wales, Scotland & England) rather than through a third party distributor.
Full Story : https://mspl.co.uk/news/
Medica '16 Thriving
Med-Tech Innovation – Dec 14, 2016
The annual Medica exhibition in Dusseldorf, Germany- adjacent to the much smaller Copamed show- typically attracts the cream of UK producers of medical and healthcare products.
A pioneering diagnostic system that is having a significant impact on the changing clinical pathway for cervical cancer was exhibited at Medica 2016 by Zilico Ltd.
Full Story : www.medtechinnovation/Medica_16
UK Cervical Cancer Diagnostic System Chosen for Pilot Study in India
MedLatest.com – Dec 13, 2016
Cervical Cancer diagnostic device specialist Zilico Ltd. has been selected by the IFC, a member of the World Bank Group, to be part of a unique program across India.
TechEmerge is the first programme of its kind that brings together proven technology companies such as Zilico, with leading healthcare providers in emerging markets.
Full Story : www.medlastest.com/Zilico_techemerge
UK cervical cancer diagnostic system to be piloted in India as part of TechEmerge's programme
Medical Device ASIA – Nov 30, 2016
Zilico Ltd- a developer of a pioneering cervical cancer diagnostic system- has been selected by the IFC, a member of the World Bank Group, to be part of a unique programme across India. (p6)
Full Story : www.medicaldeviceasia/zilico
Manchester on the Move: The UK's Industrial Engine Room is Fast Becoming a Life Science Power House
BioBusiness – Nov 23, 2016
Manchester, a city in the north of England, is a place that welcomes innovation. From the Museum of Science and Industry, to its more than 20 libraries Manchester is a city as hungry for knowledge and progress now as it ever was.(pp8-12)
Full Story : www.biobusiness/manchester/Zilico
Over 250 participants took part in the XII th National Forum of health care professionals in Shumen
Topnovini Bulgaria – Nov 11, 2016
For the 12th time Grand hotel "Shumen" brought together health care professionals across the country.
National Forum this year is entitled "Continuous care - a condition for quality of life," and it involved over 250 participants, 37 of which presented their reports.
"The contribution of nurses and midwives to provide continuous care in outpatient conditions" - prof. Sonia Tontcheva, MD - Director of Subsidiary Shumen to Varna MU, National Consultant in Health Care;
" Colposcopy and ZedScan spectroscopy in the diagnosis of precancerous cervical "- Prof. Dr. Yavor Kornovski, MD - Head of the Department of Health Care to Shumen branch of MU-Varna;
"Maxillofacial Surgery in Bulgaria - known and unknown" - Prof. Dr. Tsvetan Tonchev, MD, Ph.D. - Dean of the Faculty of Dental Medicine at MU Varna.
Full Story : www.topnovini/shumen/colpsocopy.bg
Manchester company showcases pioneering diagnostic system on world healthcare stage
Medipex.co.uk – Nov 3, 2016
A pioneering diagnostic system that is having a significant impact on the changing clinical pathway for cervical cancer will be on display at MEDICA 2016 – the largest healthcare exhibition in the world - by Manchester based Zilico Ltd.
Full Story : www.medipex.co.uk/zilico
Pioneering diagnostic system to be showcased at MEDICA 2016
Building Better Healthcare – Nov 3, 2016
ZedScan will have a significant impact on the clinical pathway for cervical cancer
Full Story : building better healthcare.co.uk/zilico
A pioneering diagnostic system that is having a significant impact on the changing clinical pathway for cervical cancer will be exhibited by Zilico in Hall 16, Stand F18-5 at MEDICA 2016, which takes place from 14–17 November in Duesseldorf.
Cervical Cancer Diagnostic System at MEDICA 2016
MedLatest.com – Nov 2, 2016
A frequent visitor to our pages, UK device company Zilico Ltd., is showcasing its pioneering cervical cancer diagnostic technology at this year’s Medica 2016.
Full Story : www.medlatest.com/zilico
Cervical cancer: New scanners help fight against disease in the Midlands
Midlands Express and Star – Sep 28, 2016
The University Hospitals of North Midlands NHS Trust has adopted the diagnostic system, called ZedScan, at the gynaecology departments at both the Royal Stoke University Hospital and the County Hospital.
Full Story : www.expressandstar.com
HSJ awards 2016 shortlist revealed
Health Services Journal – Sep 28, 2016
The shortlisted organisations will now complete presentations and interviews to a specific judging panel made up of senior and influential figures from the health sector. The winners will be announced at a prestigious ceremony on 23 November at the InterContinental O2, London.
Full Story : www.hsj.co.uk/2016awards
Zilico Shortlisted for Prestigious Healthcare Award
Business Daily – Sep 28, 2016
Manchester based Zilico has been shortlisted in the ‘Improving Care with Technology’ category at the 2016 Health Service Journal (HSJ) Awards, to be held on 23 November at Intercontinental O2, London
Full Story : www.bdaily.co.uk/Zilico
Manchester firm's pioneering technology for cervical cancer diagnosis
The BusinessDesk.com – Sep 27, 2016
PIONEERING technology created by a Manchester company is now being used in two hospitals in Staffordshire to improve the speed and accuracy in diagnosing pre-cancerous conditions of the cervix.
Full Story : www.thebusinessdesk.com/pioneering_technology
Pioneering Technology Created By Manchester Company Used In Staffordshire To Offer More Accurate Cervical Cancer Diagnosis
InvestInManchester.com – Sep 27, 2016
Pioneering technology created by a Manchester company is now being used in two hospitals in Staffordshire to improve the speed and accuracy in diagnosing pre-cancerous conditions of the cervix.
Full Story : www.investinmanchester.com/zilico
Real Time Smear Test Offering More Accurate Cervical Cancer Diagnosis in UK Hospitals
MedLatest.com – Sep 27, 2016
ZedScan Portable Cervical Smear System adopted in two more UK hospitals
Full Story : www.medlatest.com/zedscan
Staffordshire Hospitals offer more accurate cervical cancer diagnosis
Building Better Healthcare – Sep 27, 2016
The University Hospitals of North Midlands NHS Trust have adopted an innovative cervical cancer diagnostic system called ZedScan at the gynaecology departments at both the Royal Stoke University Hospital and County Hospital Stafford. Its aim is to offer a more accurate diagnosis for women who are at risk of cervical cancer.
Full Story : www.bbh/ZedScan_adoption_Staffs
Women could get faster cervical cancer diagnosis at Stafford's County Hospital
Staffordshire Newsletter – Sep 27, 2016
Women could get faster and more accurate diagnoses of pre-cancerous conditions of the cervix now Stafford's County Hospital has introduced a pioneering new technology.
ZedScan is a portable, handheld device which can measure and detect tissue changes in women identified with an abnormal smear test.
Full Story : www.stafforshirenewsletter.co.uk/new technology
ZedScan delivers high rates of HG CIN detection in hrHPV positive women
News Medical – Apr 13, 2016
A review into the management of more than 800 women referred to an NHS colposcopy clinic who were positive for high risk HPV (hrHPV) has revealed a substantial increase in detection of high grade cervical intraepithelial neoplasia (HG CIN) following the adoption of ZedScan into routine use.
Full Story : www.news-medical.net/ZedScan
A Long Adoption Trail
The Times: SuperNorth Supplement – Mar 17, 2016
Zilico features in the SuperNorth Supplement of The Times discussing the support provided by the Academic Health Science Networks (AHSNs) to assist northern-based SMEs operating in the Life Sciences sector. (see page 7 of 12)
Full Story : www.TheTimes.co.uk/SuperNorth
Conquering the Challenges of Colposcopy
The Pathologist – Feb 29, 2016
A device that uses electrical impedance spectra to characterize abnormal cervical tissue may improve on the subjective nature of colposcopy and reduce the rate of cervical biopsy.
Full Story : www.thepathologist.com
1000 patient case study published for ZedScan
Building Better Helthcare – Jan 26, 2016
Zilico has published a 1,000-patient case study for its cervical cancer diagnostic system, ZedScan, to coincide with the start of Cervical Cancer Prevention Week this week.
The patient review into the routine use of ZedScan as an adjunct to colposcopy has revealed that the technology significantly increases the rate of detection of high-grade cervical intraepithelial neoplasia (HG CIN).
Full Story : http://www.buildingbetterhealthcare.co.uk
UK company touts study of its cancer diagnostic
Fierce Medical Devices – Jan 26, 2016
U.K. company Zilico has published a case study of its diagnostic for high-grade cervical intraepithelial neoplasia, dubbed ZedScan. Use of the technology improved the detection rate of the cancer by 12.4%, the company says. It uses electrical impedance spectroscopy to differentiate between normal, precancerous and cancerous tissues.
Full Story : www.fiercemedicaldevices.com
Zilico bolsters team with new commercial director
Manchester Evening News – Jan 14, 2016
Andrew Saipe, who has 25 years’ experience in medical sales, joins Zilico from Purple Surgical, where he looked after many of the International markets for eight years.
Full Story : Manchester Evening News
NICE publishes Medtech Innovation Briefing on ZedScan
Building Better Healthcare – Feb 26, 2015
NICE has developed a Medtech Innovation Briefing outlining the benefits of using Zilico’s cervical cancer diagnostic system, ZedScan. These include lower biopsy rates, a reduction in overtreatment and adverse events, and a cost saving from the reduction in follow-up appointments
Full Story : www.buildingbetterhealthcare/ZedScan
NICE publishes Medtech Innovation Briefing on ZedScan
News Medical – Feb 24, 2015
The National Institute for Health and Care Excellence (NICE) has developed a Medtech Innovation Briefing (MIB) on Zilico Ltd’s cervical cancer diagnostic system, ZedScan.
NICE first developed the briefings in 2013 to help boost and speed-up the uptake of innovative and promising technologies which have the potential to improve patient health and increase NHS productivity.
Full Story : www.news-medical.net
ZedScan featured on BBC
BBC Look North – Oct 31, 2014
BBC Business and Money Correspondent, Danni Hewson, interviews Prof. John Tidy from Sheffield Teaching Hospitals Foundation Trust (STH) along with a patient who underwent a ZedScan examination, after referral to coloposcopy following an abnormal smear test.
Sameer Kothari, Zilico's Chief Executive also discusses how ZedScan can have a global impact on patient care.
Full Story : https:// BBCnews/ZedScan
Sheffield leads the way for cervical cancer diagnosis
The Star, Sheffield – Oct 22, 2014
Patients at Sheffield Teaching Hospitals are to benefit from the introduction of a pioneering new system that improves the detection of precancerous abnormalities of the cervix.
The trust has become the first in the country to introduce the Zedscan device, which can measure and detect tissue changes in women identified with an abnormal smear test.
Full Story : http://www.thestar.co.uk/news/health
Yorkshire Post – Oct 21, 2014
Women in Yorkshire will be the first in the country to benefit from a pioneering approach devised by experts in the region to improve the detection of the early signs of a common cancer.
Hospital staff in Sheffield have successfully tested a device which can measure and detect tissue changes in women with an abnormal smear test.
It offers more accurate detection of pre-cancerous abnormalities of the cervix than standard examinations, allowing doctors to make better informed decisions on a patient’s first visit.
Experts say it means appropriate treatment can be started quickly, or patients can be swiftly reassured if analysis shows nothing of concern. It also reduces unnecessary tissue biopsies.
Full Story : http://www.yorkshirepost.co.uk/
First NHS trust to adopt ZedScan as part of cervical cancer care pathway
News-Medical.net – Oct 17, 2014
DP Medical Ltd has secured a deal with Sheffield Teaching Hospitals NHS Foundation Trust (STHFT) to become the first NHS Trust in the country to adopt ZedScan™ as part of its cervical cancer care pathway.
The ground-breaking system, which includes its patented Electrical Impedance Spectroscopy technology, offers quicker and more accurate detection of cervical neoplasia delivering results in real-time, enabling clinicians to improve patient management.
Full Story : http://www.news-medical.net/
Zilico Success in Australia
Triteq – Jun 24, 2014
Triteq have worked with Zilico Ltd, a spin-out company from Sheffield Teaching Hospitals NHS Foundation Trust and the University of Sheffield, from the initial concept stage of Zedscan 1, a ground breaking cervical cancer diagnostic device. So we were delighted to hear that ZedScan I has obtained approval from Therapeutic Goods Administration (TGA) in Australia.
Full Story : https://triteq.com/news/
Relocating a small business: the pros, cons and necessary preparations
The Guardian – Mar 21, 2014
Manchester has also been a destination for some relocating companies, including medical sciences business Zilico which moved across the Pennines from Sheffield in late 2012.
At the time the company had just finished a multi-centre trial, was looking for a bigger hub and wanted to be based closer to an international airport, said Zilico's chief executive Sameer Kothari.
The move to Manchester Science Park helped Zilico access private equity finance and support from north-west-based NHS trusts. "I can't say it was specifically because we were based in Manchester, but it did help," says Kothari.
Full Story : www.theguardian.com
Real-time cervical cancer diagnostics: An interview with Sameer Kothari, Chief Executive of Zilico
News-Medical.net – Mar 19, 2014
Sameer Kothari outlines the current limitations of the diagnostic process for cervical cancer and discusses how the development of ZedScan, Zilico's cervical cancer diagnostic system, will improve diagnostic accuracy.
Full Story : www.news-medical.net
Doctor, our start-ups need a cash injection
The Sunday Times – Mar 2, 2014
Medical tech companies need constant care if they are to survive and grow
Bruce Hellman swiped his finger over his iPad screen. “This is how patients are reminded to take their medication,” he said, “and they can choose a brain training exercise.”
Full Story : The Sunday Times
Zilico receives EC Certification for ZedScan
Clinical Services Journal – Feb 6, 2014
ZILICO has received EC certification from its Notified Body for the ZedScan cervical cancer diagnostics device, which is said to offer faster and more accurate detection of cervical neoplasia in real-time, enabling clinicians to improve patient management.
The ZedScan system is used alongside colposcopy on women identified with an abnormal smear result. It can offer clinical benefits by identifying the optimum biopsy site, reducing the number of cervical biopsies required while also facilitating a wider use of ‘select & treat’.
The system, which is both safe and painless, consists of a portable hand-held device and docking station, software application and a single-use EIS sensor. Five clinical trials in the UK and EU have supported the clinical efficacy of ZedScan, including a pivotal European trial of 429 women in 2011 across three hospitals in the UK and Ireland.
Full Story : www.clinical services journal.com
Zilico Ltd cervical cancer diagnostics tool
Hospital Healthcare – Nov 12, 2012
Zilico Ltd will present its pioneering cervical cancer diagnostics tool at Medica 2012 - the world’s premier healthcare exhibition.
Full Story : http://www.hospitalhealthcare.com